This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
BAG1 / BAG family molecular chaperone regulator 1 · IHC design guide
Design Immunohistochemistry for BAG1
Plan BAG1 staining in paraffin sections using the predominantly nuclear tissue pattern (HPA tissue IHC). Compare positive and negative cell populations while accounting for tissue-dependent isoform expression (UniProt).
Evidence assembled Oct 2026 · For research use; verify linked source records and product datasheet before use
BAG1 Immunohistochemistry Experimental Design Guide
Expected localisation, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
Must know before staining
| Expected localisation | Nuclear staining in most tissues (HPA tissue IHC) | |
| Staining pattern | Nuclear staining across most tissues (HPA tissue IHC) | |
| Antigen retrieval | EDTA pH 8.0 HIER, heat-mediated (datasheet A02423-2) | |
| Positive control | Appendix+4 more · see all | |
| Negative control | Adipose tissue+4 more · see all |
Important caveats
Reasons your staining may differ from the expected pattern.
| Fixation | Matched tissue-IHC evidence does not establish the fixation claim. Validate the specimen-specific method before use. (selected-SKU IHC image A02423-2) | |
| Caveat | Isoform 4 expression varies by tissue (UniProt) | |
| Regulation | Tissue-dependent isoform expression (UniProt) | |
| Isoform / epitope | 4 isoforms; verify antibody epitope coverage (UniProt) |
Section 1
Recommended BAG1 IHC & IF Protocols
Compare the catalog antibody’s IHC-P protocol (datasheet: A02423-2) with two published lung cancer tissue protocols (PMC4734146; PMC8247369).
| Sample | Paraffin-embedded human breast cancer tissue; fixative not specified (datasheet A02423-2) |
| Fixation | Image fixative and duration unreported (datasheet A02423-2); verify before use. |
| Sectioning | 4–5 µm sections on charged slides (standard) |
| Deparaffinisation | Xylene, graded ethanol series to water (standard) |
| Antigen retrieval | Heat retrieval: EDTA pH 8.0 (datasheet A02423-2); 20 min, 95–100 °C (standard) |
| Peroxidase block | 3% H2O2, 10 min, room temperature (standard) |
| Blocking | 10% goat serum (datasheet A02423-2) |
| Primary antibody | Rabbit anti-BAG1, 2-5μg/ml (datasheet A02423-2) |
| Primary incubation | Overnight at 4 °C (datasheet A02423-2) |
| Detection | HRP-conjugated secondary, DAB chromogen (datasheet A02423-2) |
| Counterstain | Hematoxylin, blue, dehydrate and mount (standard) |
| Expected result | BAG1-positive staining in endocrine cells of appendix (HPA tissue IHC: High). HPA tissue profile: Nuclear expression in most tissues. No signal in the no-primary control. |
💡Decision noteStart with heat-mediated EDTA retrieval at pH 8.0 (datasheet: A02423-2); the published excerpts do not specify retrieval conditions (PMC4734146; PMC8247369).
Section 2
What Is the Expected BAG1 Staining Pattern?
BAG1 should show predominantly nuclear staining in many tissue cell types, with cytoplasmic signal also biologically plausible (HPA: nuclear expression in most tissues; UniProt Q99933: nucleus and cytoplasm). Prioritize the listed high-staining cell populations, such as colon endocrine cells and lung alveolar type II cells (HPA: High). The tissue IHC profile has Supported reliability, with medium consistency between staining and RNA data (HPA: Supported). BAG1 has no transmembrane segment (UniProt Q99933 topology).
| Distinct nuclear staining in the expected cells, possibly with weaker cytoplasmic staining. | This agrees with the dominant tissue pattern (HPA: nuclear expression in most tissues) and reported cytoplasmic localization (UniProt Q99933). Compare cells within the same section; nuclear signal in the expected population is more persuasive than uniform color across every compartment (general IHC interpretation). |
| Predominantly membrane outlining, with little convincing nuclear staining. | A membrane-dominant pattern conflicts with BAG1's reported nuclear and cytoplasmic locations and lack of a transmembrane segment (UniProt Q99933). Review morphology, antibody specificity and chromogen deposits before scoring it as BAG1 (general IHC interpretation). Cytoplasmic staining alone is less decisive because that compartment is reported (UniProt Q99933). |
| Strong staining in a cell population listed as not detected, such as adipocytes, while expected positive cells are unstained. | That distribution disagrees with the reference profile (HPA: adipocytes Not detected; colon endocrine cells High). Consider cross-reactivity or endogenous detection activity, particularly if the signal ignores cell boundaries (general IHC interpretation). A single discordant field does not establish either cause; assess controls and tissue morphology (general IHC practice). |
| Diffuse color covers nuclei, cytoplasm, extracellular spaces and slide background. | A continuous haze cannot establish BAG1 localization (general IHC interpretation). Check whether the negative reagent control shares the haze, then assess blocking, washing and detection background (general IHC practice). HPA's tissue pattern describes cellular nuclear expression; it does not validate diffuse extracellular staining (HPA: tissue IHC profile). |
| No visible signal in a listed high-staining population, such as gallbladder glandular cells. | This fails the selected positive-control expectation (HPA: gallbladder glandular cells High). Check that the glandular cells are present, then review antibody and detection performance, retrieval conditions and section quality (general IHC practice). A failed control makes negative results in other specimens difficult to interpret (general IHC interpretation). |
💡Expected BAG1 appearanceCall a section positive when its expected cells show clear, mainly nuclear staining, allowing some cytoplasmic signal (HPA: nuclear expression in most tissues; UniProt Q99933: nucleus and cytoplasm); high staining is reported in colon endocrine cells and lung alveolar type II cells (HPA: High), whereas membrane-only outlines or uniform background warrant review (general IHC interpretation).
| Which cells provide a reference pattern? | Use the specified cell population, not an entire organ, as the comparator: appendix and duodenum endocrine cells and cervix glandular cells are High, while adipocytes and smooth muscle cells are Not detected (HPA: tissue IHC). These levels describe observed staining, not universal positive or negative status for every cell in those tissues (HPA: tissue IHC). |
| What does an apparent cytoplasmic component mean? | Cytoplasmic staining can fit BAG1 localization (UniProt Q99933: cytoplasm), although nuclear expression predominates in tissue IHC (HPA: tissue IHC). The distinct ICC-IF reference places BAG1 mainly in the nucleoplasm and additionally in the cytosol (HPA: supported subcellular localization). |
| Can isoforms change interpretation? | Four BAG1 isoforms are listed; isoform 1 is predominantly nuclear (UniProt Q99933). Isoform 4 has broad reported expression with specified exceptions (UniProt Q99933). The supplied record does not map an IHC antibody epitope to those isoforms, so a staining difference cannot be assigned to one isoform from this evidence alone. |
| Is retrieval or epitope behavior predictable? | No BAG1-specific retrieval condition or fixation sensitivity is supplied. Retrieval optimization against a known-positive section is general IHC practice. The listed ubiquitin-like and BAG domains and phosphoserine 223 do not, by themselves, predict epitope accessibility in paraffin sections (UniProt Q99933: domains and modified residue). |
| IF/ICC: where should BAG1 fluorescence appear? | Expect mainly nucleoplasmic fluorescence with additional cytosolic signal (HPA: supported ICC-IF subcellular localization). This is a localization cross-check, not an IHC-P protocol or an IF preparation recommendation; compare with the tissue IHC pattern separately (HPA: nuclear expression in most tissues). |
| Situation | Likely cause | Next action |
|---|---|---|
| Positive-control nuclei are blank. | The run has not reproduced a listed high-staining population (HPA: gallbladder glandular cells High). | Confirm cell identity and section quality; inspect primary antibody, retrieval and detection steps against the chosen antibody's IHC-P instructions (general IHC practice). Resolve the positive control before interpreting study negatives (general IHC interpretation). |
| A tissue expected to contain positive cells looks uniformly negative. | The relevant cell population may be absent from the section, or the run may have failed (general IHC interpretation). HPA assigns High to particular cells, such as colon endocrine cells, rather than to every colon cell (HPA: tissue IHC). | Locate the specified cells on a counterstained section and compare a separate listed high-staining control processed in the same run (general IHC practice). |
| Color appears in negative-control and test sections alike. | Shared signal suggests background from detection chemistry or insufficient blocking or washing (general IHC interpretation). It does not confirm BAG1, even where the tissue profile predicts staining (HPA: tissue IHC). | Inspect the negative reagent control and review detection chemistry, blocking and washes using general IHC controls. Score BAG1 only where cell-associated signal separates from that background (general IHC practice). |
| Strong staining outlines cell membranes, with weak or absent nuclear signal. | A membrane-dominant result disagrees with the reported localization and topology (UniProt Q99933: nucleus, cytoplasm and no transmembrane segment). | Check for edge deposits and nonspecific staining, then compare a listed high-staining tissue and the chosen antibody's validation information (general IHC practice; HPA: tissue IHC). Do not use membrane outlines alone to call BAG1 positive (general IHC interpretation). |
| Cytoplasmic staining seems stronger than nuclear staining. | Cytoplasmic BAG1 is plausible, but tissue IHC is chiefly nuclear (UniProt Q99933: cytoplasm; HPA: nuclear expression in most tissues). Relative compartment intensity alone cannot identify an isoform without epitope information (UniProt Q99933: four isoforms). | Compare well-preserved cells and controls, record nuclear and cytoplasmic components separately, and check whether the antibody's epitope is documented before proposing an isoform explanation (general IHC practice). |
| A proposed negative-control population stains strongly. | The observation conflicts with a cell-specific reference if the population is correctly identified (HPA: adipocytes, smooth muscle cells and soft-tissue fibroblasts Not detected). Cross-reactivity or endogenous detection activity is possible, not established (general IHC interpretation). | Confirm cell identity and compare negative reagent and positive tissue controls. Reassess detection background and antibody validation before treating the unexpected signal as BAG1 (general IHC practice). |
Experiment evidence
IHC & IF images showing BAG1 staining
A02423-2 · IHCIHC analysis of Bag1 using anti-Bag1 antibody (A02423-2). Bag1 was detected in a paraffin-embedded section of human breast cancer tissue. He
A02423-2 · IHCIHC analysis of Bag1 using anti-Bag1 antibody (A02423-2). Bag1 was detected in a paraffin-embedded section of human colorectal adenocarcinom
HPA · Cerebral cortexHuman Protein Atlas IHC, Cerebral cortex. Source: https://www.proteinatlas.org/ENSG00000107262-BAG1/tissue/cerebral+cortex#imid_754752
HPA · ColonHuman Protein Atlas IHC, Colon. Source: https://www.proteinatlas.org/ENSG00000107262-BAG1/tissue/colon#imid_754694
HPA · LiverHuman Protein Atlas IHC, Liver. Source: https://www.proteinatlas.org/ENSG00000107262-BAG1/tissue/liver#imid_754687
HPA · KidneyHuman Protein Atlas IHC, Kidney. Source: https://www.proteinatlas.org/ENSG00000107262-BAG1/tissue/kidney#imid_754688
HPA · ICC-IF A-431Human Protein Atlas immunofluorescence, A-431, antibody CAB002486; green = BAG1, blue = nucleus, red = microtubules.
HPA · ICC-IF A-431Human Protein Atlas immunofluorescence, A-431, antibody CAB002486; green = BAG1, blue = nucleus, red = microtubules.
← swipe / scroll for more images →
Real IHC / IF data behind the staining-pattern expectations in this section.
Sample controls for BAG1 IHC & IF
🧪Run appendix first: endocrine cells should stain strongly (HPA: High in appendix endocrine cells). Use adipose tissue as the negative comparison (HPA: Not detected in adipocytes); on the appendix slide, treat any unstained non-endocrine cells as internal contrast, without assuming that all non-endocrine cells are BAG1-negative (HPA: appendix endocrine cells High).
Positive control tissue: Appendix (Endocrine cells, HPA High)
Negative control tissue: Adipose tissue (HPA Not detected)
ICC-IF cell lines (HPA subcellular resource): HPA ICC-IF images show BAG1 in A-431, U-251MG, HeLa, SiHa, U2OS, with annotated localisation: Nucleoplasm (supported) (HPA subcellular).
Technical controls: Include a no-primary, secondary-only control; a concentration-matched rabbit IgG isotype control matched to the primary antibody’s clonality; and BAG1-knockout tissue or a validated peptide-block control (caption: rabbit primary antibody; standard IHC practice). Block endogenous peroxidase and check for background signal in appendix before interpreting DAB staining (caption: HRP/DAB detection; standard IHC practice).
⚠️Feasibility: A target-specific fixation window or fixation effect is unreported, and the selected A02423-2 paraffin-section caption does not state the fixative (selected-SKU IHC caption). That caption reports heat retrieval in EDTA at pH 8.0 and primary antibody at 2 μg/ml overnight at 4°C; it does not establish that retrieval is required for every preparation (selected-SKU IHC caption). BAG1 is found in the nucleoplasm and cytosol by ICC-IF, but the supplied evidence does not establish that frozen sections or IF are easier than paraffin IHC; assess appendix background from endogenous peroxidase during chromogenic scoring (HPA: subcellular ICC-IF; standard IHC practice).
HPA tissue IHC evidence for BAG1
Comprehensive Human Protein Atlas IHC scoring per tissue (reliability: Supported — Medium consistency between antibody staining and RNA expression data.). Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
Positive expression · recommended positive controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Appendix | Endocrine cells | High | Protein (IHC) | HPA → |
| Cervix | Glandular cells | High | Protein (IHC) | HPA → |
| Colon | Endocrine cells | High | Protein (IHC) | HPA → |
| Duodenum | Endocrine cells | High | Protein (IHC) | HPA → |
| Epididymis | Glandular cells | High | Protein (IHC) | HPA → |
Undetected expression · recommended negative controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | Adipocytes | Not detected | Protein (IHC) | HPA → |
| Adrenal gland | Glandular cells | Not detected | Protein (IHC) | HPA → |
| Bone marrow | Hematopoietic cells | Not detected | Protein (IHC) | HPA → |
| Smooth muscle | Smooth muscle cells | Not detected | Protein (IHC) | HPA → |
| Soft tissue | Fibroblasts | Not detected | Protein (IHC) | HPA → |
Section 3
Advanced BAG1 IHC Tips
Troubleshoot BAG1 staining in paraffin sections by checking retrieval, compartment, background and cell specific scoring before interpreting intensity.
How should I retrieve BAG1 when nuclear staining is weak?
Start with heat mediated retrieval in EDTA at pH 8.0 for paraffin sections (datasheet A02423-2). The selected tissue image used that retrieval, followed by 10% goat serum block and 2 μg/ml primary antibody overnight at 4°C (caption A02423-2). If staining is weak, compare a longer retrieval time on adjacent sections while keeping antibody concentration and DAB development constant (standard IHC practice). Judge recovery by clearer cell associated nuclear staining, because BAG1 is mainly nuclear in tissue IHC, while avoiding diffuse staining or damaged morphology from excessive heating (HPA tissue IHC; standard IHC practice).
Could fixation explain inconsistent BAG1 staining between paraffin blocks?
Target specific BAG1 sensitivity to fixation is unknown here: the selected paraffin section caption does not state its fixative (caption A02423-2). Record each block’s fixative, fixation duration and processing history before comparing staining, since these variables can alter antigen accessibility in paraffin IHC (standard IHC practice). Process matched control sections together and begin with EDTA at pH 8.0 heat retrieval, the documented condition for this antibody (datasheet A02423-2; standard IHC practice). If a block remains weak, adjust retrieval on adjacent sections and inspect tissue morphology; do not attribute the difference to a BAG1 specific fixation effect without direct validation (standard IHC practice).
How do I assess BAG1 staining that appears cytoplasmic instead of nuclear?
Score nuclear and cytoplasmic staining separately, since tissue IHC shows nuclear expression in most tissues, while BAG1 is also reported in cytoplasm (HPA tissue IHC; UniProt Q99933 subcellular). Predominantly nuclear staining can fit isoform 1, but compartment alone cannot identify an isoform among the 4 reported forms (UniProt Q99933 subcellular and isoforms). Check whether the signal follows intact cells and whether the counterstain clearly separates nuclei from cytoplasm (standard IHC practice). Compare adjacent sections with a no primary control and the same retrieval and DAB development to investigate diffuse cytoplasmic colour or misplaced nuclear signal (standard IHC practice).
Can this stain distinguish BAG1 isoforms or reveal a masked epitope?
Do not assign a stained nucleus to a specific BAG1 isoform without an isoform selective epitope and validation, because the record lists 4 isoforms (UniProt Q99933 isoforms; standard IHC practice). BAG1 contains a ubiquitin like region at residues 144–224, a BAG domain at 246–326, and reported phosphorylation at serine 223 (UniProt Q99933 domains and modified residues). The supplied caption does not identify this antibody’s epitope, so it cannot establish which isoforms or modified forms are detected (caption A02423-2). If staining changes with retrieval, compare adjacent sections and seek epitope mapping before interpreting the change as isoform selective (standard IHC practice).
How should I check BAG1 localisation by multiplex IF?
For a separate IF experiment, pair BAG1 with a validated marker of the cell type under study and a nuclear counterstain, then assess nuclear and cytosolic signal within the same cells (standard IF practice; HPA subcellular). HPA reports supported nucleoplasmic localisation with additional cytosolic localisation, providing a compartment check for IF images (HPA subcellular). Choose a fluorophore channel with low tissue autofluorescence, and inspect single stained controls for bleed through before interpreting overlap (standard IF practice). BAG1 has no transmembrane segment, so use controlled permeabilisation to access intracellular epitopes; optimise that step for the actual antibody epitope, which the supplied caption does not define (UniProt Q99933 topology; caption A02423-2; standard IF practice).
What should I change when BAG1 DAB staining is diffuse?
First inspect a no primary section for signal from the secondary and detection reagents, and apply a peroxidase block before HRP and DAB development (standard IHC practice). The selected image used a 10% goat serum block, 2 μg/ml rabbit primary overnight at 4°C, and an HRP based DAB readout (caption A02423-2). If background persists, titrate the primary below the documented concentration and shorten DAB development while comparing adjacent sections processed together (standard IHC practice). Retain a known positive control, and judge specificity by cell associated nuclear staining rather than uniform colour across tissue and section edges (HPA tissue IHC; standard IHC practice).
How should I quantify BAG1 across paraffin tissue sections? ⚠ ANSWER MARKED FOR VERIFICATION
Define the tissue region and eligible cell type before scoring, then report nuclear and cytoplasmic compartments separately because BAG1 has both reported localisations (UniProt Q99933 subcellular; standard IHC practice). For nuclear staining, record percentage of positive cells and intensity using a prespecified H score scale; report positive cell density per mm² when cell abundance varies (standard IHC practice). Normalise counts to eligible cells or measured viable tissue area, and exclude necrosis and section folds using the same rules across specimens (standard IHC practice). Keep retrieval, antibody concentration, imaging and DAB timing matched, since the selected caption documents 2 μg/ml primary with EDTA pH 8.0 retrieval (caption A02423-2; standard IHC practice).
How can I distinguish true BAG1 staining from artefact?
Look for staining in intact cells with a clear nuclear component: HPA describes nuclear expression in most tissues, and also reports high staining in appendix endocrine cells (HPA tissue IHC). Cytoplasmic signal can be plausible, but widespread extracellular colour, accentuation at section edges, or staining confined to necrosis warrants an artefact check (UniProt Q99933 subcellular; standard IHC practice). Compare a no primary control after the same peroxidase block and DAB development to assess background from endogenous enzyme activity or detection reagents (standard IHC practice). Interpret negative cells cautiously: HPA reports no detection in adipocytes, so cell identity and tissue context matter alongside a positive control (HPA tissue IHC; standard IHC practice).
Boster reagents
Best BAG1 / BAG family molecular chaperone regulator 1 IHC Antibodies
A02423-2 has BAG1 IHC images from human breast cancer, colorectal adenocarcinoma and tonsil, and mouse colon paraffin sections (catalog IHC captions). M02423-2 lists ICC/IF without an image (catalog applications; image fields).
Real IHC data
Anti-Bag1 Antibody ®
Cat # A02423-2
A02423-2 has IHC images from human and mouse paraffin sections and lists human, mouse and rat reactivity (catalog IHC captions; reactivity). M02423-2 lists IHC and ICC/IF for human, mouse and rat, but has no IHC or IF images in the payload (catalog applications; reactivity; image fields).
Which to pick: For paraffin-section tissue IHC, choose A02423-2: its captions document EDTA retrieval at pH 8.0, a 2 μg/ml primary antibody incubation and HRP/DAB detection; the fixative is unreported (A02423-2 IHC captions). For IF/ICC, M02423-2 is the listed option: it is rabbit monoclonal clone 28B16 with a listed IF dilution of 1:50, though no IF image is supplied (M02423-2 catalog). For cross-species work, both list human, mouse and rat reactivity; A02423-2 has IHC images from human and mouse sections, while neither SKU has a rat image in the payload (catalog reactivity; image fields).
Each figure is that product's own IHC / IF validation image from its datasheet.
References
- UniProt Consortium. UniProt entry Q99933 (BAG1_HUMAN, BAG family molecular chaperone regulator 1).
- Human Protein Atlas. BAG1 tissue IHC expression (reliability: Supported).
- Human Protein Atlas. BAG1 subcellular location (ICC-IF): Mainly localized to the nucleoplasm. In addition localized to the cytosol..
- Human Protein Atlas. BAG1 antibody validation summary (3 antibodies).
- Role of BCL2-associated athanogene in resistance to platinum-based chemotherapy in non-small-cell lung cancer. Oncology letters 2016 — PMC4734146.
- ALDH3A1 driving tumor metastasis is mediated by p53/BAG1 in lung adenocarcinoma. Journal of Cancer 2021 — PMC8247369.
- BAG1: the guardian of anti-apoptotic proteins in acute myeloid leukemia. PloS one 2011 — PMC3189928.
- PubMed PMID:8524784 — UniProt-cited evidence.
- PubMed PMID:8812483 — UniProt-cited evidence.
- PubMed PMID:15986447 — UniProt-cited evidence.
Immunohistochemistry protocol sheet for BAG1 (BAG family molecular chaperone regulator 1). Expected localisation Nuclear staining in most tissues (HPA tissue IHC). Antigen retrieval: EDTA pH 8.0 HIER, heat-mediated (datasheet A02423-2). Validated IHC antibody: A02423-2 at 2-5μg/ml (the product's own IHC validation image is shown). Controls (HPA): positive Appendix (Endocrine cells); negative Adipose tissue. IHC-P workflow on paraffin sections; fixative unspecified. Protocol steps: 1. Sample: Paraffin-embedded human breast cancer tissue; fixative not specified (datasheet A02423-2); 2. Fixation: Image fixative and duration unreported (datasheet A02423-2); verify before use.; 3. Sectioning: 4–5 µm sections on charged slides (standard); 4. Deparaffinisation: Xylene, graded ethanol series to water (standard); 5. Antigen retrieval: Heat retrieval: EDTA pH 8.0 (datasheet A02423-2); 20 min, 95–100 °C (standard); 6. Peroxidase block: 3% H2O2, 10 min , room temperature (standard); 7. Blocking: 10% goat serum (datasheet A02423-2); 8. Primary antibody: Rabbit anti-BAG1, 2-5μg/ml (datasheet A02423-2); 9. Primary incubation: Overnight at 4 °C (datasheet A02423-2). Watch for: Fixation: Matched tissue-IHC evidence does not establish the fixation claim. Validate the specimen-specific method before use. (selected-SKU IHC image A02423-2); Caveat: Isoform 4 expression varies by tissue (UniProt); Isoform / epitope: 4 isoforms; verify antibody epitope coverage (UniProt); Regulation: Tissue-dependent isoform expression (UniProt). Evidence: UniProt Q99933, HPA tissue IHC · Supported, HPA ICC-IF · Mainly localized to the nucleoplasm. In addition localized to the…, Datasheet A02423-2, PMC4734146, PMC8247369. QR code links to https://www.bosterbio.com/bosterbio-gene-info-cards/BAG1/immunohistochemistry-ihc-guide.